MedTrace Logo

Immunology of Non-specific Effects of Vaccine

NCT00168545 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2011-09-22

No results posted yet for this study

Summary

OBJECTIVES

* General: To investigate the immunological background for the non-specific effects of diphtheria-tetanus-pertussis (DTP) and measles vaccines on child mortality
* Specific: Examine the cytokine responses and possible association with morbidity in a study of DTP vaccinated children who will be randomised to receive a measles vaccine or no vaccine at 4½ months of age. (All children will receive a measles vaccine at 9 months of age)

Conditions

  • Measles
  • Diphtheria
  • Tetanus
  • Pertussis

Interventions

BIOLOGICAL

Measles vaccine

Sponsors & Collaborators

  • Novo Nordisk A/S

    collaborator INDUSTRY

  • Fonden til Lægevidenskabens Fremme

    collaborator OTHER

  • Danish Council for Development Research

    collaborator OTHER

  • Medical Research Council Unit, The Gambia

    collaborator OTHER

  • Leiden University Medical Centre, DEPT of Parasitology, Leiden Holland

    collaborator OTHER

  • Bandim Health Project

    lead OTHER

Principal Investigators

  • PETER AABY, MSc, Dr Med · Bandim Health Project

  • MAY-LILL GARLY, PHD, DTM&H · Bandim Health Project

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Months
Max Age
9 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-01-31
Completion
2007-01-31

Countries

  • Guinea-Bissau

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00168545 on ClinicalTrials.gov